Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects

NCT03928353 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PB2452 Infusion
DRUG: Placebo - Sodium Chloride
DRUG: Ticagrelor Oral Tablet - Pre-Treatment
DRUG: Ticagrelor Oral Tablet - Pre-Treatment and Post-Treatment
DRUG: Ticagrelor Oral Tablet - Pre-Treatment
DRUG: PB2452 Infusion
DRUG: Placebo - Sodium Chloride

Sponsor

SFJ Pharmaceuticals, Inc.